NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese

International Journal of Urology

Volumn 6, Issue 9, 1999, Pages 446-454

  Inatomi, Hisato ^a   Katoh, Takahiko ^b   Kawamoto, Toshihiro ^a   Matsumoto, Tetsuro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Bladder cancer; Genotype; N acetyltransferase 2 (NAT2); Phenotype; Polymorphism

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; CARCINOGEN; MARKER;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER STAGING; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC MARKER; GENOTYPE; HUMAN; JAPAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

ACETYLATION; AGED; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 0032833244     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.1999.00096.x     Document Type: Article

References (30)

1. 1 Rehn L. Blasengeschwulste bei Fuchsin-Arbeiten. Arch. Klin. Clin. 1895; 50: 588-600 (in German).
2. 2 Hueper WC, Wiley FH, Wolfe HD. Experimental production of bladder tumors in dogs by administration of beta-naphthylamine. J. Ind. Hyg. Toxicol. 1938; 20: 46-84.
3. 3 Vincis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: A systematic approach. Arch. Environ. Health 1991; 46: 6-15.
4. 4 Kunze E, Chang-Claude J, Frentzel-Beyme R. Life style and occupational risk factors for bladder cancer in Germany: A case-control study. Cancer 1992; 69: 1776-90.
5. 5 Evans DP. N-acetylyransferase. Pharmacol. Ther. 1989; 42: 157-234.
6. 6 Cartwright RA, Glasham RW, Rogers HJ et al. The role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmaco-genetic epidemiological approach to bladder cancer. Lancet 1982; 2: 842-6.
7. 7 Mommsen S, Barfold NM, Aagaard J. N-acetyltransferase phenotype in the urinary bladder carcinogenesis of a low risk population. Carcinogen 1985; 6: 199-201.
8. 8 Hlet KF, David BM, Detchon P. Castleden WM, Kwa R. Acetylation phenotype in colorectal carcinoma. Cancer Res. 1987; 47: 1466-9.
9. 9 Deguchi T, Mashimo M, Suzuki T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem 1990; 267: 18 140-7.
10. 10 Blum. M, Demierre A, Grant DM, Heim M, Meyer UA. Molecular mechanism of slow acetylation of drugs and carcinogens in Humans. Proc. Natl Acad. Sci. USA 1991; 88: 5237-41.
11. 11 Vatsis KP, Martell KJ, Weber W. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl Acad. Sci. USA 1991; 88: 6333-7.
12. 12 Hickman D, Risch A, Camilleri J, Sim E. Genotyping human polymorphic arylamine N-acetyltransferase: Identification of slow allotypic variants. Phamacogenetics 1992; 2: 217-26.
13. 13 Bell DA, Taylor JA, Butler MA et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993; 14: 1689-92.
14. 14 Mashimo M, Suzuki T, Abe M, Deguchi T. Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum. Genet. 1992; 90: 139-43.
15. 15 Delemenie C, Sica L, Grant DM, Krishnamoorthy R, Dupret JM. Genotyping of the polymorphic N-acetyltransferase (NAT2) gene locus in two native African populations. Pharmacogenetics 1996; 6: 177-85.
16. 16 Henry JL, Chun-Ya H, Bruce KL, Steven H. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1994; 4: 125-34.
17. 17 Japanese Urological Association and The Japanese Society of Pathology. General Rules for Clinical and Pathological Studies on Bladder Cancer, 2nd edn. Kanehara, Tokyo, 1993.
18. 18 Fleiss JL (ed.). Statistical Methods for Rates and Proportions, 2nd edn. John Wiley & Sons, New York, 1981.
19. 19 Hickman D, Sim E. N-acetyltransferase polymorphism: Comparison of phenotype and genotype in humans. Biochem. Pharmacol. 1991; 42: 1007-14.
20. 20 Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochem. Biophys. Acta 1988; 948: 37-66.
21. 21 Rich A, Wallace DM, Bathers S, Sim E. N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol. Genet. 1995; 4: 231-6.
22. 22 Brockmöller J, Cascorbi I, Reinhold K, Roots I. Combined analysis of inherited polymorphisms in arylarnine N-acetyltransferase 2. glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 1996; 56: 3915-25.
23. 23 Heyes RB, Bi W, Rothman N et al. N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 1993; 14: 675-8.
24. 24 Sone M. Determination of N-acetyltransferase phenotype in urothelial cancer patients and healthy controls. Hinyoukika-Kiyo 1986; 32: 1085-92 (in Japanese).
25. 25 Ishizu S, Hashida C, Hanaoka T, Maeda K, Ohishi Y, N-acetyltransferase activity in the urine in Japanese subjects: Comparison of healthy persons and bladder cancer patients. Jpn J. Cancer Res. 1995; 86: 1179-81.
26. 26 Patrianakos C, Hoffmann D. Chemical studies on tobacco smoke: 64. Analysis of aromatic amines in cigarette smoke. J. Anal. Toxicol. 1979; 3: 150-4.
27. 27 Mommsen S, Aagaard J. Susceptibility in urinary bladder cancer. Acetyltransferase phenotypes and related risk factors. Cancer Lett. 1986; 32: 199-205.
28. 28 Kadlubar FF, Butlaer MA, Kaderlik KR, Chou H-C, Lang NP. Polymorphisms for aromatic amine metabolism in humans: Relevance for human carcinogenesis. Environ. Health Perspect. 1992; 98: 69-74.
29. 29 Badawi AF, Hirveron A, Bell DA, Lang NP, Kadlubar FF. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 1995; 55: 5230-7.
30. 30 Okkels H, Sigsgaard T, Wolf H, Autrup H. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) Polymorphisms in susceptibility to Bladder Cancer: The influence of smoking. Cancer Epidemiol. Biomarkers Prev. 1997; 6: 225-31.